August 24, 2022 By Haley Nagasaki
(Globe Newswire) Kelowna — Allied Corp. is pleased to announce that following an extensive regulatory review, it has received the Brazilian Health Regulatory Agency (ANVISA) approval for Brazilian importation.
On April 27, 2022 Allied announced the signing of a forward purchase agreement for the manufacturing and sell-through of medical products destined for Brazil. On June 9, 2022 Allied further announced the successful initial shipment for this forward purchase agreement. By way of this announcement, Allied has now obtained ANVISA approval for these transactions.
The Brazilian Health Regulatory Agency controls the importation of medical products to the Brazilian market. ANVISA’s role is to promote the protection of the population’s health by executing sanitary control of the production, marketing and use of products and services subject to health regulation.
“This is an exciting day for Allied. With ANVISA’s recent approval of our products, it opens the Brazilian market for Allied. Through partnering with large medical groups in Brazil, we will now be able to bring the Allied products to the patients that need the medicine.” — James McMillan, Chief Commercial Officer, Allied Corp.
Print this page
- HYTN awarded medical cannabis sales license increasing opportunities at Kelowna facility
- Cannabix Technologies correlates THC in breath and blood in U.S. study